APOE4 gene

The APOE4 gene is a specific variant, or allele, of the apolipoprotein E gene that significantly increases an individual's risk of developing late-onset Alzheimer's disease.

The apolipoprotein E (APOE) gene provides the blueprint for a protein that is essential for metabolizing fats, including cholesterol, in the body and the brain. In the brain, APOE helps transport cholesterol to neurons, which is critical for synaptic function and repair. There are three common forms, or alleles, of the APOE gene: APOE2, APOE3, and APOE4. Every person inherits two copies of the APOE gene, one from each parent, resulting in one of six possible combinations (e.g., E2/E3, E3/E4, E4/E4). APOE3 is the most common allele and is considered neutral regarding Alzheimer's risk. APOE2 is less common and appears to offer some protection against the disease.

The APOE4 allele, present in approximately 15-25% of the general population, is the strongest known genetic risk factor for late-onset Alzheimer's disease. Inheriting one copy of APOE4 increases the risk by about two to three times, while inheriting two copies can increase the risk by as much as twelve times. It is crucial to understand that APOE4 is a risk factor, not a certainty. Many individuals with the APOE4 allele will never develop Alzheimer's, and conversely, many people with Alzheimer's do not carry the APOE4 allele.

In the context of Alzheimer's pathology, the protein produced by the APOE4 allele is believed to be less efficient at clearing beta-amyloid, a sticky protein fragment that clumps together to form the characteristic plaques found in the brains of Alzheimer's patients. The APOE4 variant may also contribute to the formation of tau tangles, another hallmark of the disease, and promote inflammation and damage to the brain's blood vessels. Beyond Alzheimer's, the APOE4 allele is also associated with an increased risk of cardiovascular disease and atherosclerosis, likely due to its central role in cholesterol metabolism.

The significance of the APOE4 gene for patients and the public lies in its role in risk assessment and disease prevention. Genetic testing can identify an individual's APOE status, but this information is not used to diagnose Alzheimer's. The decision to undergo testing is a personal one, often involving genetic counseling to understand the potential psychological and social implications. For those who carry the APOE4 allele, this knowledge can empower them to adopt proactive lifestyle modifications—such as a heart-healthy diet, regular physical activity, and cognitive engagement—which research suggests may help mitigate the increased genetic risk.

A specific variant of the apolipoprotein E gene that increases an individual's risk of developing late-onset Alzheimer's disease.

A specific variant of the apolipoprotein E gene that increases an individual's risk of developing late-onset Alzheimer's disease.